Page last updated: 2024-08-22

antimony and Leishmaniasis, American

antimony has been researched along with Leishmaniasis, American in 136 studies

Research

Studies (136)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (11.76)	18.7374
1990's	19 (13.97)	18.2507
2000's	44 (32.35)	29.6817
2010's	48 (35.29)	24.3611
2020's	9 (6.62)	2.80

Authors

Authors	Studies
Andersson, B; Bart, A; Blum, J; Bradley, M; Buffet, P; Dotevall, L; Gangneux, JP; Glans, H; Guery, R; Harms, G; Robert-Gangneux, F; Rongisch, R; Van der Auwera, G; van Henten, S; Varani, S	1
Meshkin, A; Sadeghi, F; Shadmand, E; Solhjoo, K; Taghipour, A; Tayer, AH	1
Carregal, VM; Demicheli, C; Frézard, F; Fujiwara, RT; Islam, A; Lanza, JS; Rivas, L; Souza, DM	1
Frézard, F; Gontijo, CMF; Monte-Neto, RLD; Rugani, JN; Soares, RP	1
Aguiar, MG; Azevedo, RB; Coelho, LD; Ferreira, LA; Lopes, SC; Novais, MV; Oliveira, MC; Silva, RA; Souza, PE; Tedesco, A	1
Bedoya-Pacheco, SJ; Lyra, MR; Martins, ACC; Oliveira, LFA; Pimentel, MIF; Saheki, MN; Salgueiro, MM; Schubach, AO; Senna, TCR; Valete-Rosalino, CM	1
Arana, B; Beaucage, S; Bilbe, G; Bonnet, B; Dey, R; Duncan, R; Halie, L; McWilliams, IL; Modabber, F; Rachuri, S; Robinson, S; Thacker, SG; Verthelyi, D	1
Castellucci, LC; da Hora, AS; de Almeida, LF; do Lago, TS; Machado, PR	1
Arruda, S; Carvalho, AM; Carvalho, EM; Carvalho, LP; Costa, R; Guimarães, LH; Prates, I; Saldanha, MG	1
Barral, A; Barral-Netto, M; Boaventura, V; Carvalho, EM; Corte, TWF; Guimarães, LH; Lago, T; Machado, PRL; Penna, G; Prates, FVO; Schriefer, A	1
Abreu, TM; de Jesus, AR; de Moura, TR; Dutra, BM; Fonseca, FRM; Pacheco de Almeida, R; Pompeu, MML; Rodrigues, NLC; Teixeira, CR; Teixeira, MJ	1
Ali, N; Ashraf, S; den Boer, M; Fernhout, J; Grobusch, MP; Kämink, S; Khan, SJ; Masih, B; Pylypenko, T; Ritmeijer, K; Ullah, A	1
Brito, G; de Carvalho, EM; Dourado, M; Guimarães, LH; Machado, PRL; Meireles, E; Schriefer, A	1
Barrera, MC; Fernandez, O; Gomez, MA; McMahon-Pratt, D; Rojas, LJ; Saravia, NG; Weiss, A	1
Brito, NC; Cota, GF; Rabello, A	1
Guimarães, LH; Machado, PRL; Magalhães, V; Medina, L; Queiroz, A; Schriefer, A; Silva, JA; Silva, SC	1
Dey, R; Dube, A; Gannavaram, S; Kariyawasam, KKGDUL; Karunanayake, P; Karunaweera, ND; Nakhasi, HL; Selvapandiyan, A; Senanayake, SASC; Siriwardana, HVYD	1
Campos, TM; Carvalho, EM; Carvalho, LP; Costa, RS; Lago, E; Machado, P; Magalhães, AS; Paixão, CS; Passos, ST; Schriefer, A; Scott, P; Silva, JA	1
Ait-Oudhia, K; Benikhlef, R; Eddaikra, N; Harrat, Z; Kherrachi, I; Moulti-Mati, F; Oury, B; Sereno, D	1
Çavuş, İ; Erdoğan, MA; Evren, V; Harman, M; Kılavuz, A; Özbilgin, A; Tunalı, V; Turgay, N; Yılmaz, Ö; Zorbozan, O	1
Akman-Karakaş, A; Aksoy, M; Akyol, M; Aytekin, S; Borlu, M; Doğramacı, ÇA; Durdu, M; Fettahlıoğlu Karaman, B; Gürel, MS; Harman, M; İnan Doğan, E; Kapıcıoğlu, Y; Kaya, TI; Mülayim, MK; Özbel, Y; Özensoy Töz, S; Özgöztaşı, O; Uzun, S; Yeşilova, Y	1
Gontijo, CF; Monte-Neto, RL; Quaresma, PF; Rugani, JN; Soares, RP	1
Almeida-Amaral, EE; Gervazoni, LFO; Gonçalves-Ozório, G	1
Castro, MDM; Cossio, A; Desai, MM; Prieto, MD; Uribe-Restrepo, AF	1
Moreira, DS; Murta, SMF; Peruhype-Magalhães, V; Ribeiro, CV; Rocha, BFB	1
Berman, J; Soto, J	1
López-Vélez, R; Monge-Maillo, B; Norman, FF; Pérez-Molina, JA	1
Hadighi, R; Hajjaran, H; Heidari, M; Kazemi-Rad, E; Khadem-Erfan, MB; Khamesipour, A; Mohebali, M; Raoofian, R; Rezaie, S; Saffari, M	1
Ali, MI; Andrews, PC; Badshah, A; Forsyth, CM; Junk, PC; Kedzierski, L; Kumar, I; Rauf, MK	1
Chatterjee, M; Dalton, JE; Kaye, PM; Mukhopadhyay, D	1
Barral, A; Barral-Netto, M; Costa, JM; Khouri, R; Santos, GS; Soares, G; Van Weyenbergh, J	1
Brito, G; Carvalho, EM; Carvalho, LP; Celestino, D; Dourado, M; Machado, PR; Passos, S; Polari, L; Queiroz, A	1
Barros, AB; Batista, MP; Fontes, CJ; Hueb, M; Munhoz Junior, S; Rodrigues, AM	1
Cardoso, TN; Dalastra Laurenti, M; de Paula Coelho, C; Perez Hurtado, EC; Roberti Benites, N; Rodrigues de Santana, F; Villano Bonamin, L	1
Bhattacharjee, H; Charret, KS; Mandal, G; Mandal, S; Mukhopadhyay, R; Papadopoulou, B; Sharma, M	1
Grisard, EC; Romanha, AJ; Romero, I; Steindel, M; Téllez, J	1
Aronson, NE; Lakhal-Naouar, I; Marovich, MA; Slike, BM	1
Berman, J; Paz, D; Quispe, J; Rivero, D; Soto, J; Soto, P; Toledo, J	1
Andrade, MS; Corrêa-Júnior, JD; Demicheli, C; Fernandes, FR; Ferreira, LA; Frézard, F; Lanza, JS; Magalhães-Paniago, R; Melo, MN; Vilela, JM	1
Almeida, J; Brito, MD; Carvalho, EM; Dourado, ME; Guimarães, LH; Machado, PR; Prates, FV; Schriefer, A; Silva, SC	1
Sadeghi, M; Sadeghian, G; Ziaei, H	1
Beck, JC; Berman, J; Davidson, C; Mings, S; Ondo, AL; Shanler, SD	1
Alexandrenne, C; Arevalo, J; Boelaert, M; Chappuis, F; Chizzolini, C; Dayer, JM; De Doncker, S; Decuypere, S; Dujardin, JC; Llanos-Cuentas, A; Loutan, L; Maurer-Cecchini, A; Tulliano, G	1
Akrout, F; Boudaya, S; Chaabane, H; Dammak, A; Kchaou, W; Masmoudi, A; Turki, H; Zribi, M	1
Botelho, AC; Mayrink, W; Oliveira, RC	1
Calderon, W; Cruz, M; Gyorkos, TW; Llanos-Cuentas, A; Matlashewski, G; Miranda-Verastegui, C; Rahme, E; Tulliano, G; Ward, B	1
Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Teva, A; Vieira, F	1
Caldas, ED; Neves, DB; Sampaio, RN	1
Chatterjee, M; Madhubala, R; Maharjan, M; Mandal, S; Singh, S	1
PESSOA, SB; VILLELA, F	1
Adaui, V; Arévalo, J; Cupolillo, E; Dujardin, JC; Ribeiro-Alves, M; Romero, GA; Torres, DC	1
Almeida, RP; Carvalho, EM; de Jesus, AR; de Moura, TR; Giudice, A; Guimarães, LH; Pereira, JM; Souza, AS; Wilson, ME	1
Abbas, MM; Masood, S; Mumtaz, MJ; Rashid, BN; Tabassum, S; Ullah Rao, MS	1
Adaui, V; Arévalo, J; Chappuis, F; DE Doncker, S; Decuypere, S; Dujardin, JC; Gutiérrez, A; Llanos-Cuentas, A; Maes, I; Schnorbusch, K; Vanaerschot, M; Zimic, M	1
Craft, N; Da-Cruz, AM; de Oliveira, MP; de Oliveira-Neto, MP; Maretti-Mira, AC; Pirmez, C	1
Ampuero, J; Carvalho, EM; Guimarães, LH; Machado, PR; Penna, G; Rocha, AT; Schriefer, A; Sousa, RS; Talhari, A; Villasboas, L	1
Almeida, RP; Cardoso, CR; Carregaro, V; Carvalho, EM; Costa, DL; de Jesus, AR; Giudice, Â; Lima-Júnior, DS; Milanezi, CM; Silva, JS; Silva, NM	1
Andrade, CA; Martins, MM; Marzochi, MC; Oliveira, LF; Oliveira, RV; Passos, SL; Schubach, AO	1
Motta, JO; Sampaio, RN	1
Adaui, V; Arevalo, J; De Doncker, S; Dujardin, JC; Huyse, T; Kuhls, K; Llanos-Cuentas, A; Maes, I; Maes, L; Schönian, G; Talledo, M; Van den Broeck, F	1
Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Vieira, FA	1
Chatterjee, M; Ghosh, S; Pakrashi, S; Roy, D; Sarkar, A; Sen, S	1
Arévalo, J; Chappuis, F; Dujardin, JC; Llanos-Cuentas, A; Valencia, C; Zimic, M	1
Costa, AS; Diniz, DS; Escalda, PM	1
Alavi, I; Berman, J; Cruz, M; Gracia, L; Guzman, M; Maldonado, M; Nena, W; Rojas, E; Soto, J; Toledo, J; Verduguez, A; Villarroel, D	1
Bulut, V; Gur, S; Gurel, MS; Kocyigit, A; Ulukanligil, M	1
Eissa, MM; el-Kowrany, SI; Ismail, HI; Nassar, SO; Sallam, FA	1
Bogenrieder, T; Landthaler, M; Lehn, N; Stolz, W	1
CASILE, M; SACCHARIN, H	1
PFEIFER, E	1
FLOCH, H	1
BATISTA, G; BRENER, Z; FURTADO, TA	3
HOEKENGA, MT; TUCKER, HA	1
ERCOLI, N	1
GUSEINZADE, KM	1
NARVA, WM	1
DOBRZHANSKAIA, RS	1
NEAL, RA	1
OLEFFE, J; VANBREUSEGHEM, R; VANDERMEIREN, L	1
YOKOKAWA, K	1
Beck, B; Blum, J; Desjeux, P; Hatz, C; Schwartz, E	1
LAVERDE, A	1
Allahverdiyev, AM; Culha, G; Durdu, M; Memisoglu, HR; Uzun, S	1
Almeida, RP; Carvalho, EM; de Jesus, AR; Machado, PR; Magalhães, A; Salgado, K; Santos, JB	1
Faber, WR; Kager, PA; Steketee, WH; van Thiel, PP; Wetsteyn, JC; Zeegelaar, JE	1
Gómez, A; Henao, HH; Osorio, Y; Saravia, NG; Travi, B	1
Bouassida, S; Boudaya, S; Maalej, N; Masmoudi, A; Mseddi, M; Souissi, A; Turki, H; Zahaf, A	1
Batroff, B; Feldmeier, H; Fraga, F; Harms, G; Oliveira, F	1
Aronson, N; Lesho, EP; Neafie, R; Wortmann, G	1
Almeida, RP; Brito, J; Carvalho, EM; DE Jesus, AR; Guimarães, LH; Machado, PL; Schriefer, A	1
Abdel Hamid, MM; El Azhari, M; El Hassan, AM; Elamin, EM; Elkadaro, AM; Guerbouj, S; Guizani, I; Ibrahim, ME; Khalil, EA; Mohamed, HS; Mukhtar, MM; Musa, AM	1
Bouassida, S; Kitar, A; Masmoudi, A; Rebai, M; Turki, H; Zahaf, A	1
Atabek, ME; Pirgon, O; Unal, E	1
Ouellette, M; Rojas, R; Saravia, NG; Valderrama, L; Valderrama, M; Varona, MX	1
Akhyani, M; Barikbin, B; Ghodsi, ZS; Jafari, AK; Toosi, S; Valikhani, M	1
Buffet, PA; Darie, H; Freitag, S; Gounod, N; Le Guern, AS; Therby, A; Van Der Vliet, D	1
Ather, S; Chan, DS; Harding, KG; Leaper, DJ	1
Dowlati, Y; Eskandari, SE; Firooz, A; Ghoorchi, MH; Gorouhi, F; Hooshmand, B; Khamesipour, A; Khatami, A; Nassiri-Kashani, M; Rashighi-Firoozabadi, M	1
Cruz, A; Herwaldt, BL; Palacios, R; Rainey, PM; Saravia, NG; Stagni, G; Trujillo, R	1
Al Jaser, MH; Al Rayes, ZR; Radwan, MA	1
Dowlati, Y; Firooz, A; Gorouhi, F; Khatami, A	1
Abou Alsoud, N; Al-Jaser, M; Alnaim, L; Zaghloul, I	1
Mumtaz, N; Rahman, SB; ul Bari, A	1
Minodier, P; Parola, P	1
Adaui, V; Arevalo, J; Chappuis, F; De Doncker, S; Dujardin, JC; Lazo, M; Llanos-Cuentas, A; Loayza-Muro, R; Maurer, A; Miranda-Verástegui, C; Ramirez, L; Tulliano, G; Zimic, M	1
Mahajan, VK; Sharma, NL	1
Azeredo-Coutinho, RB; Callahan, H; Max, G; Mendonça, SC; Portal, AC	1
Bittar, RC; Coutinho, SG; Da-Cruz, AM; Mattos, MS; Nogueira, RS; Oliveira-Neto, MP; Pinho-Ribeiro, V; Vieira-Gonçalves, R	1
Akrout, F; Ayadi, N; Bouassida, S; Boudaya, S; Khabir, A; Masmoudi, A; Meziou, TJ; Sallemi, T; Turki, H; Zahaf, A	1
Dahdah, MJ; Ghosn, S; Kibbi, AG	1
Koff, AB; Rosen, T	1
Dedet, JP; Lambert, M; Pratlong, F	1
Croft, SL; el-Yazigi, A; Jaser, MA	1
al Jaser, M; Croft, SL; el-Yazigi, A; Kojan, M	1
Blum, J; Hatz, C; Junghanss, T	1
Prada, JL; Sánchez-Guijó, P; Torre-Cisneros, J; Valverde, F; Villanueva, JL	1
Furtado, T; Nogueira-Castañon, MC; Pereira, CA	1
Barroeta, S; Bonfante-Garrido, R; de Alejos, MA; Grimaldi Júnior, G; Meléndez, E; Momen, H; Torrealba, J; Valdivia, O	1
Bertho, AL; Coutinho, SG; Da-Cruz, AM; De Luca, PM; McMahon-Pratt, D; Mendonça, SC; Oliveira, MP; Soong, L	1
Bai, M; Kastanioudakis, I; Kostoula, A; Skevas, A	1
Agudelo, S; Berman, J; Grogl, M; Hendrickx, E; Modabber, F; Puerta, J; Velez, I	1
Abuloham, O; al-Majali, O; Bhowmik, KR; Hebeheba, H; Muhsen, M; Routh, HB	1
da Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A	1
Gonçalves-Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A	1
Aktepe, N; Avci, S; Erel, O; Gurel, MS; Kocyigit, A; Seyrek, A; Vural, H	1
Alvarez, R; Fortuño, B; García, R; Sánchez, M; Simal, E; Yus, C	1
Acar, MA; Memişoğlu, HR; Ozpoyraz, M; Uslular, C; Uzun, S; Yücel, A	1
Herwaldt, BL	1
Benchimol, E; Brahin, LR; Martins, VJ; Mattos, MS; Oliveira-Neto, MP; Pirmez, C	1
Afonso, LC; Costa , CA; Genaro, O; Gollob, KJ; Mayrink, W; Oliveira, MA; Pinto, JA; Toledo, VP	1
Angelo, C; Gradoni, L; Grosso, MG; Ludovisi, A; N'Doni, F; Paradisi, M; Puddu, P	1
Arana, B; Diaz, A; Rizzo, N	1
Hepburn, NC	1
Marr, JJ; Martinez, S	1

Reviews

15 review(s) available for antimony and Leishmaniasis, American

Article	Year
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review. PloS one, 2017, Volume: 12, Issue:9 Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cryotherapy; Databases, Factual; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2017
Post kala-azar dermal leishmaniasis: an unresolved mystery. Trends in parasitology, 2014, Volume: 30, Issue:2 Topics: Antimony; Antiprotozoal Agents; Genetic Predisposition to Disease; Humans; Leishmaniasis, Cutaneous; T-Lymphocytes; Ultraviolet Rays	2014
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta tropica, 2011, Volume: 118, Issue:2 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Leishmaniasis, Cutaneous; Pentamidine	2011
Treatment of cutaneous leishmaniasis among travellers. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Administration, Topical; Animals; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Travel; Treatment Failure	2004
Nonhealing skin lesions in a sailor and a journalist returning from Iraq. Cleveland Clinic journal of medicine, 2005, Volume: 72, Issue:2 Topics: Adult; Antimony; Diagnosis, Differential; Female; Humans; Iraq; Journalism; Leishmaniasis, Cutaneous; Male; Military Medicine; Military Personnel; Recurrence; Warfare	2005
Case report and literature review of leishmaniasis as a cause of leg ulceration in the United Kingdom. Journal of wound care, 2006, Volume: 15, Issue:9 Topics: Afghanistan; Animals; Antimony; Antiprotozoal Agents; Causality; Diagnosis, Differential; Humans; Insect Bites and Stings; Insect Vectors; Leg Ulcer; Leishmaniasis, Cutaneous; Male; Middle Aged; Prognosis; Psychodidae; Skin Care; Travel; United Kingdom; Wound Healing	2006
Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:2 Topics: Administration, Topical; Antimony; Azoles; Cryotherapy; Humans; Leishmaniasis, Cutaneous; Paromomycin; Randomized Controlled Trials as Topic; Zinc Sulfate	2007
Cutaneous leishmaniasis treatment. Travel medicine and infectious disease, 2007, Volume: 5, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Humans; Imiquimod; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Paromomycin; Pentamidine; Phosphorylcholine	2007
Therapeutic options for cutaneous leishmaniasis. The Journal of dermatological treatment, 2007, Volume: 18, Issue:2 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Dapsone; Humans; Imidazoles; Leishmaniasis, Cutaneous; Rifampin	2007
Treatment of cutaneous leishmaniasis. Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:5 Pt 1 Topics: Americas; Antimony; Humans; Leishmaniasis, Cutaneous; World Health Organization	1994
[Leishmaniasis and human immunodeficiency virus infections]. Presse medicale (Paris, France : 1983), 1995, Jun-17, Volume: 24, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Female; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male	1995
[The therapy of cutaneous and mucocutaneous leishmaniasis]. Deutsche medizinische Wochenschrift (1946), 1994, Aug-26, Volume: 119, Issue:34-35 Topics: Allopurinol; Animals; Antimony; Hot Temperature; Humans; Imidazoles; Leishmania braziliensis; Leishmania guyanensis; Leishmania major; Leishmania mexicana; Leishmania tropica; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Pentamidine	1994
Leishmaniasis. Lancet (London, England), 1999, Oct-02, Volume: 354, Issue:9185 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male	1999
Chemotherapy of cutaneous leishmaniasis: a review. Medical microbiology and immunology, 2001, Volume: 190, Issue:1-2 Topics: Antifungal Agents; Antimony; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Ointments; Organometallic Compounds; Phosphorylcholine	2001
Management of cutaneous leishmaniasis. Current opinion in infectious diseases, 2001, Volume: 14, Issue:2 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child, Preschool; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Mice	2001

Trials

18 trial(s) available for antimony and Leishmaniasis, American

Article	Year
Healing effects of autologous platelet gel and growth factors on cutaneous leishmaniasis wounds in addition to antimony; a self-controlled clinical trial with randomized lesion assignment. BMC research notes, 2023, Sep-09, Volume: 16, Issue:1 Topics: Adult; Antimony; Blood Platelets; Humans; Intercellular Signaling Peptides and Proteins; Leishmaniasis, Cutaneous; Male; Wound Healing	2023
A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-05, Volume: 73, Issue:7 Topics: Antimony; Antiprotozoal Agents; Brazil; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophage Colony-Stimulating Factor; Phosphorylcholine; Treatment Outcome	2021
Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis. The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Brazil; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Interferon-gamma; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Middle Aged; Pentoxifylline; Treatment Outcome; Tumor Necrosis Factor-alpha	2017
Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline. The American journal of tropical medicine and hygiene, 2014, Volume: 90, Issue:4 Topics: Adult; Antimony; Chemokine CCL3; Chemokine CXCL10; Chemokine CXCL9; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Interferon-gamma; Interleukin-10; Leishmaniasis, Cutaneous; Male; Pentoxifylline; Pilot Projects; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult	2014
Intralesional Pentamidine: A Novel Therapy for Single Lesions of Bolivian Cutaneous Leishmaniasis. The American journal of tropical medicine and hygiene, 2016, Volume: 94, Issue:4 Topics: Adult; Antimony; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Pentamidine; Treatment Outcome; Trypanocidal Agents	2016
Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jan-01, Volume: 64, Issue:1 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Brazil; Female; Fluconazole; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Middle Aged; Treatment Outcome; Young Adult	2017
First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony. PLoS neglected tropical diseases, 2009, Jul-28, Volume: 3, Issue:7 Topics: Adolescent; Adult; Aged; Aminoquinolines; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunologic Factors; Leishmaniasis, Cutaneous; Male; Middle Aged; Peru; Toll-Like Receptor 7; Treatment Outcome; Young Adult	2009
Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. PLoS neglected tropical diseases, 2010, Dec-21, Volume: 4, Issue:12 Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Middle Aged; Nausea; Phosphorylcholine; Prevalence; Treatment Outcome; Vomiting; Young Adult	2010
A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:3 Topics: Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Pilot Projects; Treatment Outcome	2012
Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:9 Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Bolivia; Child; Cryotherapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Middle Aged; Placebos; Treatment Outcome; Young Adult	2013
Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis. Infection and immunity, 2002, Volume: 70, Issue:12 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Cytokines; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2002
Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study. The Journal of infectious diseases, 2004, Nov-15, Volume: 190, Issue:10 Topics: Administration, Topical; Adolescent; Adult; Antimony; Antiprotozoal Agents; Brazil; Double-Blind Method; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Recombinant Proteins; Time Factors; Treatment Outcome	2004
Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Archives of dermatology, 2006, Volume: 142, Issue:12 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Animals; Antimony; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Single-Blind Method; Treatment Outcome	2006
Miltefosine in cutaneous leishmaniasis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2007, Volume: 17, Issue:3 Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2007
Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Annals of internal medicine, 1997, Feb-01, Volume: 126, Issue:3 Topics: Adult; Allopurinol; Antimetabolites; Antimony; Antiprotozoal Agents; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Failure	1997
A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. International journal of dermatology, 1997, Volume: 36, Issue:6 Topics: Administration, Cutaneous; Adolescent; Adult; Anti-Infective Agents; Antimony; Cicatrix; Cryosurgery; Female; Follow-Up Studies; Humans; Hyperpigmentation; Hypopigmentation; Leishmaniasis, Cutaneous; Male; Nitrogen; Remission Induction; Sulfamethoxazole; Trimethoprim; Trypanocidal Agents	1997
Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens. Pathologie-biologie, 1997, Volume: 45, Issue:6 Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1997
Allopurinol in the treatment of American cutaneous leishmaniasis. The New England journal of medicine, 1992, Mar-12, Volume: 326, Issue:11 Topics: Adolescent; Adult; Allopurinol; Antimony; Antiprotozoal Agents; Child, Preschool; Developing Countries; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992

Other Studies

103 other study(ies) available for antimony and Leishmaniasis, American

Article	Year
Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122 Topics: Antimony; Antiprotozoal Agents; Humans; Leishmania major; Leishmania tropica; Leishmaniasis, Cutaneous; Retrospective Studies; Transients and Migrants; Treatment Outcome	2022
Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine. Parasitology research, 2019, Volume: 118, Issue:10 Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice, Inbred BALB C; Nanoparticles; Phosphorylcholine	2019
Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake. Memorias do Instituto Oswaldo Cruz, 2019, Volume: 114 Topics: Antimony; Aquaglyceroporins; Drug Resistance; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Parasitic Sensitivity Tests; Protozoan Proteins; Real-Time Polymerase Chain Reaction; Trypanocidal Agents	2019
Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis. Photodiagnosis and photodynamic therapy, 2019, Volume: 28 Topics: Administration, Topical; Animals; Antimony; Indoles; Leishmaniasis, Cutaneous; Liposomes; Mesocricetus; Mice, Inbred BALB C; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Spleen	2019
Clinical features and therapeutic response in adult and pediatric patients with American tegumentary leishmaniasis in Rio de Janeiro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020, 01-06, Volume: 114, Issue:1 Topics: Adolescent; Adult; Antimony; Brazil; Child; Humans; Incidence; Leishmaniasis, Cutaneous; Retrospective Studies; United States	2020
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. PLoS neglected tropical diseases, 2020, Volume: 14, Issue:2 Topics: Animals; Antimony; Cell Line; Chemokines; Female; Gene Expression Regulation; Humans; Leishmania major; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Macaca fascicularis; Male; Oligodeoxyribonucleotides	2020
FLI1 gene influences lesion size and skin test may predict therapeutic response in cutaneous leishmaniasis. Memorias do Instituto Oswaldo Cruz, 2020, Volume: 115 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Polymorphism, Single Nucleotide; Retrospective Studies; Skin Tests; Wound Healing; Young Adult	2020
Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis. The Journal of infectious diseases, 2021, 02-13, Volume: 223, Issue:3 Topics: Adolescent; Adult; Aged; Antimony; Brazil; CD8-Positive T-Lymphocytes; Cytokines; Female; Granzymes; Humans; Inflammation; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Matrix Metalloproteinase 9; Middle Aged; Necrosis; Skin; Th1 Cells; Young Adult	2021
CXCL10 immunomodulatory effect against infection caused by an antimony refractory isolate of Leishmania braziliensis in mice. Parasite immunology, 2021, Volume: 43, Issue:3 Topics: Animals; Antimony; Brazil; Chemokine CXCL10; Female; Immunologic Factors; Interleukin-10; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophages; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Th1 Cells	2021
Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Child; Female; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Middle Aged; Patient Outcome Assessment; Phosphorylcholine; Retrospective Studies; Treatment Failure; Young Adult	2021
Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility. Acta tropica, 2017, Volume: 176 Topics: Antimony; Antiprotozoal Agents; Drug Resistance; Gene Expression Profiling; Host-Parasite Interactions; Humans; Leishmania guyanensis; Leishmaniasis, Cutaneous; Macrophages	2017
Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients. Acta tropica, 2018, Volume: 178 Topics: Animals; Antimony; Antiprotozoal Agents; Brazil; DNA, Protozoan; Genetic Variation; Genotype; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Molecular Epidemiology; Treatment Failure	2018
Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies. Parasitology, 2018, Volume: 145, Issue:4 Topics: Adolescent; Adult; Aged; Animals; Antimony; Child; Child, Preschool; Clinical Studies as Topic; Cytokines; Follow-Up Studies; Humans; Infant; Interferon-gamma; Interleukin-10; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lymph Nodes; Macrophages; Male; Mice; Mice, Inbred BALB C; Middle Aged; Skin; Spleen; Sri Lanka; Virulence; Young Adult	2018
Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy. The Journal of infectious diseases, 2018, 02-14, Volume: 217, Issue:5 Topics: Adult; Antimony; Antiprotozoal Agents; Cross-Sectional Studies; Cytokines; Female; Humans; Inflammation; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Secondary Prevention; Treatment Failure; Young Adult	2018
Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:3 Topics: Algeria; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Dogs; Drug Resistance; Humans; Inhibitory Concentration 50; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Psychodidae; Rodentia	2018
[Infecting glial cells with antimony resistant Leishmania tropica: A new ex-vivo model]. Mikrobiyoloji bulteni, 2018, Volume: 52, Issue:1 Topics: Animals; Antimony; Cells, Cultured; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Neuroglia; Parasitology; Rats; Rats, Sprague-Dawley	2018
Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. International journal of dermatology, 2018, Volume: 57, Issue:8 Topics: Algorithms; Amphotericin B; Antimony; Antiprotozoal Agents; Cryotherapy; Delphi Technique; Diagnosis, Differential; Evidence-Based Medicine; Humans; Leishmaniasis, Cutaneous; Organometallic Compounds; Practice Guidelines as Topic; Turkey	2018
Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 108 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Species Specificity; THP-1 Cells	2018
2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:12 Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Drug Resistance; Female; Flavanones; Humans; Leishmania; Leishmaniasis, Cutaneous; Macrophages; Mice; Mice, Inbred BALB C; Parasite Load	2018
Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study. The American journal of tropical medicine and hygiene, 2019, Volume: 100, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Child; Colombia; Cross-Sectional Studies; Cryotherapy; Female; Humans; Hyperthermia, Induced; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Male; Middle Aged; Paromomycin; Pentamidine; Practice Guidelines as Topic; Severity of Illness Index	2019
Mannosyltransferase (GPI-14) overexpression protects promastigote and amastigote forms of Leishmania braziliensis against trivalent antimony. Parasites & vectors, 2019, Jan-25, Volume: 12, Issue:1 Topics: Antimony; Antiprotozoal Agents; Drug Resistance; Glycosylphosphatidylinositols; Leishmania braziliensis; Leishmaniasis, Cutaneous; Mannosyltransferases; Phenotype; Protozoan Proteins	2019
Reply to Monge-Maillo et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:10 Topics: Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Male	2013
Concerns about topical treatment for new world cutaneous leishmanisis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:10 Topics: Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Male	2013
Overexpression of ubiquitin and amino acid permease genes in association with antimony resistance in Leishmania tropica field isolates. The Korean journal of parasitology, 2013, Volume: 51, Issue:4 Topics: Amino Acid Transport Systems; Antimony; Antipruritics; Drug Resistance; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Protozoan Proteins; Ubiquitin	2013
Anti-leishmanial activity of heteroleptic organometallic Sb(v) compounds. Dalton transactions (Cambridge, England : 2003), 2013, Dec-28, Volume: 42, Issue:48 Topics: Antimony; Antiprotozoal Agents; Cells, Cultured; Humans; Leishmania major; Leishmaniasis, Cutaneous; Models, Molecular; Organometallic Compounds	2013
SOD1 plasma level as a biomarker for therapeutic failure in cutaneous leishmaniasis. The Journal of infectious diseases, 2014, Jul-15, Volume: 210, Issue:2 Topics: Adult; Antimony; Antiprotozoal Agents; Biomarkers; Cells, Cultured; Female; Gene Expression Profiling; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Failure	2014
Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds. Memorias do Instituto Oswaldo Cruz, 2014, Volume: 109, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Virus Activation	2014
Modulation of inflammation response to murine cutaneous Leishmaniasis by homeopathic medicines: Antimonium crudum 30cH. Homeopathy : the journal of the Faculty of Homeopathy, 2014, Volume: 103, Issue:4 Topics: Animals; Antimony; Brazil; Disease Models, Animal; Homeopathy; Inflammation; Leishmaniasis, Cutaneous; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Spleen	2014
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:2 Topics: 3' Untranslated Regions; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Aquaglyceroporins; Aquaporin 1; Cell Movement; Drug Resistance; Gene Expression Regulation; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; RNA, Messenger; RNA, Protozoan	2015
Upregulation of Cysteine Synthase and Cystathionine β-Synthase Contributes to Leishmania braziliensis Survival under Oxidative Stress. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Antimony; Antiprotozoal Agents; Cell Line; Cystathionine beta-Synthase; Cysteine Synthase; Humans; Hydrogen Peroxide; Leishmania braziliensis; Leishmaniasis, Cutaneous; Oxidative Stress; Protozoan Proteins; Transcriptional Activation; Trypanosoma rangeli; Up-Regulation	2015
The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:10 Topics: Adolescent; Adult; Antimony; Cell Proliferation; Cohort Studies; Drug Therapy; Female; Flow Cytometry; Humans; Hyperthermia, Induced; Interferon-gamma; Leishmania major; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Lymphocyte Subsets; Male; Middle Aged; Young Adult	2015
Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis. International journal of nanomedicine, 2016, Volume: 11 Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Female; Hydrophobic and Hydrophilic Interactions; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Microscopy, Atomic Force; Nanoparticles; Organometallic Compounds; Scattering, Small Angle; Solvents; Treatment Outcome; X-Ray Diffraction	2016
Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime. Annals of the Academy of Medicine, Singapore, 2008, Volume: 37, Issue:11 Topics: Administration, Oral; Adult; Animals; Antimony; Antiprotozoal Agents; Atrial Premature Complexes; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Prospective Studies; Ventricular Premature Complexes	2008
Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease. The American journal of tropical medicine and hygiene, 2009, Volume: 80, Issue:1 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Biopsy; Bolivia; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Middle Aged; Phosphorylcholine; Travel; Treatment Outcome	2009
Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. Infection and immunity, 2009, Volume: 77, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Cytokines; Female; Gene Expression Profiling; Humans; Infant; Leishmaniasis, Cutaneous; Macrophages; Male; Middle Aged; Peru; Prospective Studies; Skin; T-Lymphocytes; Treatment Outcome; Young Adult	2009
[Cryotherapy with or without intralesional antimony in the treatment of cutaneous leishmaniasis]. Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:3 Topics: Animals; Antimony; Combined Modality Therapy; Cryotherapy; Humans; Leishmania major; Leishmaniasis, Cutaneous	2009
Alterations in phenotypic profiles of peripheral blood cells from patients with human American cutaneous leishmaniasis following treatment with an antimonial drug and a vaccine. Acta tropica, 2009, Volume: 112, Issue:2 Topics: Adolescent; Adult; Aged; Animals; Antigens, CD; Antimony; Antiprotozoal Agents; Brazil; Child; Drug Therapy, Combination; Female; Humans; Leishmania; Leishmaniasis Vaccines; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Middle Aged; Young Adult	2009
Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta). Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Kidney; Leishmania braziliensis; Leishmaniasis, Cutaneous; Liver; Macaca mulatta; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spleen	2010
Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate. Tropical medicine & international health : TM & IH, 2009, Volume: 14, Issue:12 Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Treatment Outcome	2009
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:3 Topics: Amino Acid Sequence; Antimony; Antiprotozoal Agents; Aquaporin 1; DNA, Protozoan; Drug Resistance; Gene Expression Profiling; Genes, Protozoan; Humans; India; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Models, Biological; Models, Molecular; Molecular Sequence Data; Parasitic Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Sequence Alignment; Sequence Analysis, DNA; Transfection	2010
[New observations on the treatment of cutaneous leishmaniasis by antimon-detoxin]. Revista paulista de medicina, 1946, Volume: 28, Issue:3 Topics: Antimony; Leishmaniasis; Leishmaniasis, Cutaneous	1946
Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2010, Volume: 10, Issue:6 Topics: Animals; Antimony; Antiprotozoal Agents; Brazil; Drug Resistance; Gene Expression Profiling; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasites; Treatment Outcome	2010
Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC infectious diseases, 2010, Jul-15, Volume: 10 Topics: Antimony; Antiprotozoal Agents; Brazil; Cells, Cultured; Drug Resistance; Humans; Interleukin-10; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophages; Nitric Oxide; Tumor Necrosis Factor-alpha	2010
Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2010, Volume: 20, Issue:7 Topics: Antimony; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2010
Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology, 2011, Volume: 138, Issue:2 Topics: Animals; Antimony; Cell Culture Techniques; Drug Resistance; Gene Expression Profiling; Genetic Pleiotropy; Genetic Variation; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; NADH, NADPH Oxidoreductases; Ornithine Decarboxylase; Parasitic Sensitivity Tests	2011
Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression. Clinical and experimental immunology, 2011, Volume: 163, Issue:2 Topics: Adult; Antimony; Antiprotozoal Agents; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Leishmaniasis, Cutaneous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regeneration; Skin; Transforming Growth Factor beta; Treatment Failure	2011
BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production. PLoS neglected tropical diseases, 2011, Mar-01, Volume: 5, Issue:3 Topics: Animals; Antimony; Antiprotozoal Agents; Brazil; Disease Models, Animal; Drug Resistance; Female; Humans; Interleukin-4; Leishmania braziliensis; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Rodent Diseases; Skin; Th1 Cells; Th2 Cells	2011
Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2011, Volume: 11, Issue:8 Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Genetic Variation; Genotype; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Microsatellite Repeats; Parasitic Sensitivity Tests; Peru; Treatment Outcome	2011
Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate. Journal of toxicology and environmental health. Part A, 2012, Volume: 75, Issue:2 Topics: Animals; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Erythrocytes; Female; Half-Life; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macaca mulatta; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction; Reproducibility of Results; Spectrophotometry, Atomic; Thyroid Gland; Tissue Distribution	2012
Leishmania strains causing self-healing cutaneous leishmaniasis have greater susceptibility towards oxidative stress. Free radical research, 2012, Volume: 46, Issue:5 Topics: Antimony; Free Radicals; Humans; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Macrophages; Nitric Oxide; Oxidative Stress; Phosphorylcholine; Superoxide Dismutase	2012
Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Case-Control Studies; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Leishmaniasis, Cutaneous; Male; Middle Aged; Peru; Sensitivity and Specificity; Skin Ulcer; Treatment Failure; Young Adult	2012
The effect of age on the frequency of adverse reactions caused by antimony in the treatment of American tegumentary leishmaniasis in Governador Valadares, State of Minas Gerais, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 2012, Volume: 45, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Antimony; Antiprotozoal Agents; Brazil; Child; Female; Humans; Leishmaniasis, Cutaneous; Logistic Models; Male; Middle Aged; Socioeconomic Factors; Surveys and Questionnaires; Wound Healing; Young Adult	2012
The role of Fas system [Fas-FasL] as an inducer of apoptosis in cutaneous leishmaniasis: a combined human and experimental study. Journal of the Egyptian Society of Parasitology, 2001, Volume: 31, Issue:1 Topics: Animals; Antimony; Apoptosis; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Female; Humans; Leishmania major; Leishmaniasis, Cutaneous; Male; Membrane Glycoproteins; Mice; Rifampin; RNA, Messenger; Skin	2001
Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:3 Topics: Adolescent; Antimony; Antiprotozoal Agents; Equipment Design; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2003
[Treatment of American leishmaniasis]. Bulletin de la Societe de pathologie exotique et de ses filiales, 1953, Volume: 46, Issue:2 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Cutaneous	1953
[On the therapy of espundia]. Zeitschrift fur Tropenmedizin und Parasitologie, 1954, Volume: 5, Issue:2 Topics: Antimony; Arsphenamine; Humans; Leishmaniasis; Leishmaniasis, Cutaneous	1954
[The activity of intramuscular glucantime and of intravenous anthiomaline in the treatment of sylvan American leishmaniasis]. Publication. Cayenne, French Guiana. Institut Pasteur de la Guyane francaise et de l'Inini, 1955, Volume: 16, Issue:353 Topics: Antimony; Furans; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
[Therapeutic trails in American tegumental leishmaniasis. I. Sodium antimonyl-gluconate (triostib)]. Hospital (Rio de Janeiro, Brazil), 1959, Volume: 55, Issue:2 Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Schistosomicides; Sodium; United States	1959
[Therapeutic trials in tegumental American leishmaniasis. II. TWSb]. Hospital (Rio de Janeiro, Brazil), 1959, Volume: 55, Issue:3 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Succinates	1959
[Therapeutic trials in American cutaneous leishmaniasis. III. Sodium stibogluconate]. Hospital (Rio de Janeiro, Brazil), 1959, Volume: 55, Issue:4 Topics: Antimony; Antimony Sodium Gluconate; Enzyme Inhibitors; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; United States	1959
Treatment of American dermal leishmaniasis with a special oral dosage form of tartar emetic. The American journal of tropical medicine and hygiene, 1959, Volume: 8, Issue:3 Topics: Antimony; Antimony Potassium Tartrate; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Succinates; United States	1959
Chemotherapeutic studies on cutaneous leishmaniosis. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1961, Volume: 106 Topics: Amebicides; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antimony; Dermatologic Agents; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous	1961
[Treatment of cutaneous tuberculoid leishmaniasis]. Azerbaidzhanskii meditsinskii zhurnal = Aserbaidschanische medizinische Zeitschrift, 1963, Volume: 2 Topics: Antimony; Diathermy; Electrocoagulation; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Quinacrine	1963
CUTANEOUS LEISHMANIASIS. Archives of dermatology, 1964, Volume: 89 Topics: Antimony; Benzenesulfonates; Biopsy; Dermatology; Humans; Injections, Intramuscular; Leishmaniasis; Leishmaniasis, Cutaneous; Organometallic Compounds	1964
[CUTANEOUS LEISHMANIASIS OF THE EYE]. Vestnik dermatologii i venerologii, 1964, Volume: 38 Topics: Antimony; Conjunctiva; Drug Therapy; Geriatrics; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Ophthalmology	1964
CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE. Annals of tropical medicine and parasitology, 1964, Volume: 58 Topics: Amidines; Animals; Antimony; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Dapsone; Deoxyribonuclease I; Emetine; Hyaluronoglucosaminidase; Hydrastis; Leishmania tropica; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Mice; Pathology; Pharmacology; Primaquine; Pyrimethamine; Quinacrine; Research; Streptodornase and Streptokinase; Streptokinase; Sulfonamides; Surface-Active Agents; Toxicology	1964
[5 CASES OF CUTANEOUS LEISHMANIASIS]. Archives belges de dermatologie et de syphiligraphie, 1964, Volume: 20 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Quinacrine	1964
[AMERICAN LEISHMANIASIS, A CASE REPORT]. Jibi inkoka Otolaryngology, 1965, Volume: 37 Topics: Antimony; Brazil; Chloroquine; Drug Therapy; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous	1965
[American leishmaniasis in hospitals of Bogotá Colombia]. Bulletin de la Societe de pathologie exotique et de ses filiales, 1952, Volume: 45, Issue:1 Topics: Antimony; Colombia; Hospitals; Humans; Leishmaniasis; Leishmaniasis, Cutaneous	1952
Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey. The Journal of parasitology, 2004, Volume: 90, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Cryosurgery; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Turkey	2004
Changing pattern of imported cutaneous leishmaniasis in the Netherlands. Clinical and experimental dermatology, 2005, Volume: 30, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Incidence; Itraconazole; Leishmaniasis, Cutaneous; Male; Middle Aged; Netherlands; Pentamidine; Polymerase Chain Reaction; Retrospective Studies	2005
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application]. Biomedica : revista del Instituto Nacional de Salud, 2004, Volume: 24, Issue:4 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2004
[Glucantime injection: benefit versus toxicity]. Medecine et maladies infectieuses, 2005, Volume: 35, Issue:1 Topics: Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Exanthema; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pain; Retrospective Studies	2005
Cutaneous leishmaniasis associated with extensive lymphadenopathy during an epidemic in Ceará State, northeast Brazil. Acta tropica, 2005, Volume: 93, Issue:3 Topics: Adolescent; Adult; Animals; Antibodies, Protozoan; Antimony; Brazil; Child; Disease Outbreaks; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Lymphatic Diseases; Male; Middle Aged; Polymerase Chain Reaction; Skin Tests	2005
Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials. The American journal of tropical medicine and hygiene, 2005, Volume: 73, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Animals; Antimony; Brazil; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Recombinant Proteins	2005
Uncommon clinical presentations of cutaneous leishmaniasis in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2005, Volume: 99, Issue:11 Topics: Adult; Animals; Antifungal Agents; Antimony; Child; Female; Humans; Ketoconazole; Leishmaniasis, Cutaneous; Male; Polymerase Chain Reaction; Sudan	2005
[The cutaneous leishmaniasis of the face in Gafsa area, Tunisia]. Bulletin de la Societe de pathologie exotique (1990), 2005, Volume: 98, Issue:5 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Endemic Diseases; Facial Dermatoses; Female; Humans; Incidence; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Necrosis; Nose Diseases; Organometallic Compounds; Prospective Studies; Skin Ulcer; Tunisia	2005
Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes. The Journal of infection, 2006, Volume: 53, Issue:4 Topics: Adolescent; Antimony; Antiprotozoal Agents; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Knee; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2006
Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. The Journal of infectious diseases, 2006, May-15, Volume: 193, Issue:10 Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Resistance; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Failure; U937 Cells	2006
Bilateral cutaneous leishmaniasis of upper eyelids: a case report. Dermatology online journal, 2006, Jan-27, Volume: 12, Issue:1 Topics: Antimony; Child; Eyelid Diseases; Female; Humans; Leishmaniasis, Cutaneous	2006
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy. The American journal of tropical medicine and hygiene, 2006, Volume: 75, Issue:2 Topics: Adult; Animals; Anti-Infective Agents; Antimony; Antiprotozoal Agents; Cartilage; Ciprofloxacin; Ear, External; Humans; Immunocompetence; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pseudomonas Infections; Rifampin	2006
Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate. The Journal of infectious diseases, 2007, Feb-15, Volume: 195, Issue:4 Topics: Adult; Antimony; Area Under Curve; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds; Plasma	2007
The effects of induced diabetes and cutaneous Leishmania infection on the pharmacokinetics of antimony in hamsters. Annals of tropical medicine and parasitology, 2007, Volume: 101, Issue:2 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Diabetes Mellitus, Experimental; Drug Administration Routes; Female; Leishmaniasis, Cutaneous; Male	2007
Effects of fluconazole on the pharmacokinetics and pharmacodynamics of antimony in cutaneous leishmaniasis-infected hamsters. International journal of antimicrobial agents, 2007, Volume: 29, Issue:6 Topics: Administration, Oral; Animals; Antifungal Agents; Antimony; Antiprotozoal Agents; Area Under Curve; Cricetinae; Drug Therapy, Combination; Fluconazole; Half-Life; Injections, Intravenous; Leishmaniasis, Cutaneous; Mesocricetus; Random Allocation	2007
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. The Journal of infectious diseases, 2007, Jun-15, Volume: 195, Issue:12 Topics: Animals; Antimony; Antiprotozoal Agents; Geography; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Species Specificity; Treatment Failure	2007
Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis. The Journal of parasitology, 2007, Volume: 93, Issue:3 Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Inhibitory Concentration 50; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Outcome	2007
T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis. Memorias do Instituto Oswaldo Cruz, 2007, Volume: 102, Issue:5 Topics: Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Endemic Diseases; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Lymphocyte Activation; Male; Organometallic Compounds; T-Lymphocytes	2007
[Clinical and histological study of lupoid cutaneous leishmaniasis (16 cases)]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:12 Pt 1 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Biopsy; Child; Disease Progression; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Skin; Time Factors; Treatment Outcome	2007
Mutilating lupoid leishmaniasis: twelve years to make the diagnosis! Dermatology (Basel, Switzerland), 2008, Volume: 216, Issue:2 Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Biopsy; Chronic Disease; Diagnosis, Differential; Follow-Up Studies; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Remission Induction; Skin; Time Factors	2008
Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis. Pharmaceutical research, 1995, Volume: 12, Issue:1 Topics: Absorption; Adult; Antimony; Antimony Sodium Gluconate; Humans; Individuality; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Middle Aged; Therapeutic Equivalency; Tissue Distribution	1995
Skin uptake, distribution, and elimination of antimony following administration of sodium stibogluconate to patients with cutaneous leishmaniasis. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2 Topics: Adult; Antimony; Antimony Sodium Gluconate; Half-Life; Humans; Leishmaniasis, Cutaneous; Male; Skin	1995
Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal amphotericin B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:6 Topics: Adult; Amphotericin B; Antimony; Drug Resistance; Female; Humans; Leishmaniasis, Cutaneous; Liposomes	1994
Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome. International journal of dermatology, 1996, Volume: 35, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV Antibodies; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1996
Disseminated American cutaneous leishmaniasis. International journal of dermatology, 1996, Volume: 35, Issue:8 Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Azure Stains; Biopsy; Child; Cricetinae; Culture Media; Cytodiagnosis; Drug Administration Schedule; Drug Resistance; Female; Histiocytes; Humans; Injections, Intradermal; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin Tests; Skin Ulcer; Venezuela	1996
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Experimental parasitology, 1996, Volume: 84, Issue:2 Topics: Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Female; Humans; Interferon-gamma; Interleukin-2; Interleukin-4; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; T-Lymphocytes	1996
Old-world leishmaniasis of the auricle. Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044 Topics: Adult; Antimony; Antiprotozoal Agents; Ear Diseases; Ear, External; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1997
Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission. International journal of dermatology, 1997, Volume: 36, Issue:6 Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Brazil; Costs and Cost Analysis; Female; Follow-Up Studies; Humans; Injections, Intralesional; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Recurrence; Remission Induction; Skin Ulcer; Treatment Outcome; Wound Healing	1997
Effects of antimonial therapy on serum zinc, copper and iron concentrations in patients with cutaneous Leishmaniasis in Turkey. Journal of the Egyptian Society of Parasitology, 1998, Volume: 28, Issue:1 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Copper; Humans; Iron; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trace Elements; Turkey; Zinc	1998
[Efficacy of intralesional treatment with antimonials in four cases of cutaneous leishmaniasis]. Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17, Issue:2 Topics: Aged; Antimony; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Middle Aged	1999
Cutaneous leishmaniasis: evaluation of 3,074 cases in the Cukurova region of Turkey. The British journal of dermatology, 1999, Volume: 140, Issue:2 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Cryotherapy; Evaluation Studies as Topic; Female; Humans; Infant; Infant, Newborn; Leishmaniasis, Cutaneous; Male; Middle Aged; Seasons; Sex Distribution; Turkey	1999
South American cutaneous leishmaniasis of the eyelids: report of five cases in Rio de Janeiro State, Brazil. Ophthalmology, 2000, Volume: 107, Issue:1 Topics: Aged; Animals; Antimony; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Chlorides; Eye Infections, Parasitic; Eyelid Diseases; Eyelids; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Retrospective Studies	2000
Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Memorias do Instituto Oswaldo Cruz, 2001, Volume: 96, Issue:1 Topics: Adult; Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; Cytokines; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-10; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines	2001
[A Pediatric case of lupoid leishmaniasis diagnosed by PCR]. Minerva pediatrica, 2001, Volume: 53, Issue:1 Topics: Administration, Oral; Animals; Antifungal Agents; Antimony; Antiprotozoal Agents; Child; Diagnosis, Differential; DNA, Protozoan; Drug Therapy, Combination; Follow-Up Studies; Humans; Itraconazole; Leishmania infantum; Leishmaniasis, Cutaneous; Lupus Vulgaris; Male; Meglumine; Polymerase Chain Reaction; Time Factors	2001